https://onrarebridgebio.podbean.com/
On Rare | BridgeBio Pharma
rarebridgebiopharma
https://job-boards.greenhouse.io/bridgebio
Jobs at BridgeBio Pharma
jobs atbridgebiopharma
https://www.globenewswire.com/news-release/2024/12/03/2990518/0/en/Unnatural-Products-Announces-BridgeBio-Exercises-Option-to-License-Macrocyclic-Therapeutics-for-Development-in-Rare-Diseases-and-Oncology.html
Unnatural Products Announces BridgeBio Exercises Option to
Dec 3, 2024 - Unnatural Products Announces BridgeBio Exercises Option to License Macrocyclic Therapeutics for Development in Rare Diseases and Oncology ...
unnaturalproductsannouncesbridgebioexercises
https://druganalyst.com/BridgeBio/Drugs
BridgeBio Drug Sales & Forecasts - DRUGANALYST
drug salesbridgebioforecasts
https://bridgebio.com/patients/support
Support | BridgeBio
May 7, 2026 - BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.
supportbridgebio
https://druganalyst.com/BridgeBio/BBP_418
BBP-418 (BBP-418) - BridgeBio Sales History and Forecasts - DRUGANALYST
sales historybbpbridgebioforecasts
https://www.biopharmadive.com/news/bridgebio-kyowa-kirin-achondroplasia-drug-deal/706814/
BridgeBio sells partial rights to dwarfism drug for $100M | BioPharma Dive
The deal hands Kyowa Kirin rights in Japan to the drug, which is emerging as a potential rival to BioMarin’s marketed medicine Voxzogo.
biopharma divebridgebio
https://bbotx.com/
BridgeBio Oncology Therapeutics (BBOT) | Best-in-RAS
Sep 11, 2025 - Redefining what’s possible in precision oncology to treat RAS-dependent cancers. Inhibiting Active RAS. Going beyond current approaches.
best inbridgebiooncologytherapeuticsbbot
https://bridgebio.com/terms-of-use
Terms of Use | BridgeBio
May 4, 2026 - BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.
terms of usebridgebio